Skip to main content
Premium Trial:

Request an Annual Quote

Bluebee Joins OpenPower Foundation


NEW YORK (GenomeWeb) – Bluebee has joined the OpenPower Foundation, an open development community that leverages the IBM Power architecture.

The OpenPower foundation, which includes IBM, Google, Altera, Xilinx, aims to create advanced server, storage, and networking acceleration technology as well as open source software that will provide more choice, control, and flexibility to developers of heterogeneous cloud-based data centers. Bluebee, along with other members, will participate in the workgroup that aims to build reference architecture for high performance genetic data analysis.

Bluebee's participation in the consortium "emphasizes [its] ambition to play a distinctive role in the broader rollout of high performance and cloud-based data analytics for genomics," Hans Cobben, the company's CEO, said in a statement. "We strongly believe that taking on an important role in the OpenPower Foundation will help [in] shaping an emerging market by combining two disruptive technologies, [namely,] cloud computing and genomics."

Earlier this month, Bluebee signed a distribution agreement with Convey Computer, the terms of which state that both companies can sell their respective software products to clients in the next-generation sequencing market.

The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.